Capital flows, CMO moves, M&A. Eight editions a day, seven tiers, from the chopped neck.
ISABELLA'S ISLAYM&A IntelligenceOct 9, 11:01 AM EDT
Drug distributor McKesson and private equity firm Clayton Dubilier & Rice agreed to take infusion therapy provider Option Care private in a $5.8 billion transaction.
ReadingPE has confirmed healthcare services are now consolidation targets, not growth bets. Margins compress for operators outside the combine.
WatchCD&R's next announcement will be in home health or dialysis. The pattern is already written.
HENRI IVCapital MarketsOct 9, 11:01 AM EDT
Global private equity and venture capital-backed companies completed exits in a $227 billion market despite a 17% drop in deal volume.
ReadingMid-market PE returns are now contingent on finding the right strategic buyer, not the most aggressive one. Auction processes are contracting.
WatchNext quarter's data. If volume falls another 15%, the definition of a viable exit shifts.
MACALLAN 1926M&A IntelligenceOct 9, 11:01 AM EDT
GTCR completed the acquisition of Tactacam, a previously private-equity-backed action camera maker, in a transaction valued above $1 billion.
ReadingHardware entrepreneurs calling themselves platforms need to understand they are now shopping for a sponsor's playbook, not capital.
WatchGTCR's integration plan. If they consolidate Tactacam with another portfolio company, the category is narrowing.
LOUIS XIIIVenture IntelligenceOct 9, 11:01 AM EDT
TRexBio and Retension Pharmaceuticals priced their initial public offerings, raising a combined $161.7 million to fund their immunology and hypertension pipelines before their NASDAQ debuts.
ReadingThe biotech IPO window remains real but shrinking. Timing now matters more than narrative.
WatchTheir first earnings calls. If either shows pipeline acceleration, the next cohort reprices upward.
PAPPY 23M&A IntelligenceOct 9, 11:01 AM EDT
Bain Capital Private Equity completed the acquisition of a 9.75% stake in Baudroie, Inc. (TSE:4413) for ¥9.3 billion, signaling PE interest in Japanese mid-market operators.
ReadingMinority stakes are now positioning moves for PE, not passive investments. Watch for the follow-on announcement.
WatchWhether Bain files a Schedule 13D or moves toward control. The first filing tells you everything about the next two years.
JOHNNIE BLUEGlobal Business NewsOct 9, 11:01 AM EDT
Kakao announced a spin-off plan designed to increase corporate value, but the proposal has faced growing controversy and the stock price has fallen in response.
ReadingAsian conglomerates calling for strategic splits now need to prove the math, not just the theory. Shareholders are no longer patient with process.
WatchWhether Kakao revises the plan or doubles down. The next earnings call will be the inflection.
WELL POURVenture IntelligenceOct 9, 11:01 AM EDT
Smart ring maker Oura postponed its $2.1 billion IPO, which was scheduled to debut this week, citing unfavorable market conditions.
ReadingHardware IPO calendars are now backward: announce the move first, then price. The earlier model is dead.
WatchWhether Oura files a revised S-1 within 90 days or falls silent for two quarters.
Leave catalogs to the libraries and archives. Join Brand101, the standard in brand identity → huanggoodman.com/brand-room